Product Details

Tecentriq 840 mg/14 mL

Atezolizumab
840 mg/14 mL
Concentrate for solution for infusion

ROA

Intravenous

Applicant Name

Roche Products Limited

NRN

A6-100033

Status

Active


Composition

Each 14 mL contains: Atezolizumab 840 mg Excipients: Recombinant Human Hyaluronidase (rHuPH20), L-Histidine, Acetic Acid, L-Methionine, Polysorbate 20, Sucrose, Water for injections  

ATC Code/ATCvet Code

L01FF05  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 1's (in vial)  

Product Description

Concentrate for solution for infusion Clear, colorless to slightly yellowish liquid. The solution has a pH of 5.5 - 6.1 and an osmolality of 129 - 229 mOsm/kg

Manufacturer Name

F. Hoffmann-La Roche Ltd

Manufacturer Country

SWITZERLAND  

Approval Date

2021-10-28  

Expiry Date

2026-10-27